Product Images Sildenafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 22 images provide visual information about the product associated with Sildenafil NDC 27808-163 by Tris Pharma Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a product information for Sildenafil, which is a medication used for treating erectile dysfunction. The text provides instruction for the reconstitution of oral suspension of 10 mg/mL. It also includes storage instructions, dosage recommendations, and warnings to keep it out of reach of children. An oral dosing syringe and a bottle adapter are provided in the package. The product comes in a 112 mL bottle following reconstitution.*
This appears to be a table showing the change from baseline measurements in meters over the course of a study, labeled by week. The key indicates different treatments administered, including a placebo and various doses of Sildenafil. It is not clear what the study is investigating and therefore not possible to provide additional context or description.*
The plot is showing the mean change from baseline for different treatments at each visit up to week 12, measured in meters. The treatments are represented by different codes, but it is not clear what they stand for. Unfortunately, there is not enough context to provide a more useful description.*
The text is not-available as it consists of only a few fragmented words and does not form a coherent description.*
This text provides a list of drugs and their recommended dosages with respect to interacting drug fold change and 90% CI. The dosages to be adjusted and not to be adjusted are mentioned for each drug. The last line mentions that the addition of sildenafil to bosentan therapy does not provide any benefit in exercise capacity, as per clinical studies.*
This is a list of drugs that interact with Acenocoumarol. The text includes the names of the interacting drugs, INR AUC, INR Cmax, BT, AuC, Cmax and its fold change and 90% CI. Recommendations for dose adjustments and co-administration of drugs are also included, with some of the drugs requiring no dose adjustment and some co-administrations not being recommended. The text also mentions the effects of the co-administration of sidenafil and bosentan, with no benefit on exercise capacity observed.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.